Protalix BioTherapeutics (PLX) FCF Margin (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,266.00 |
| Dec 31, 2025 | 5,544.00 |
| Sep 30, 2025 | 1,170.00 |
| Jun 30, 2025 | 1,884.00 |
| Mar 31, 2025 | -7,945.00 |
| Dec 31, 2024 | 646.00 |
| Sep 30, 2024 | 4,201.00 |
| Jun 30, 2024 | -11,904.00 |
| Mar 31, 2024 | 6,494.00 |
| Dec 31, 2023 | 9,550.00 |
| Sep 30, 2023 | -7,826.00 |
| Jun 30, 2023 | 4,745.00 |
| Mar 31, 2023 | -427.00 |
| Dec 31, 2022 | 3,619.00 |
| Sep 30, 2022 | 1,658.00 |
| Jun 30, 2022 | -4,469.00 |
| Mar 31, 2022 | 2,708.00 |
| Dec 31, 2021 | -4,629.00 |
| Sep 30, 2021 | -11,546.00 |
| Jun 30, 2021 | 18,730.00 |
| Mar 31, 2021 | -5,188.00 |
| Dec 31, 2020 | -406.00 |
| Sep 30, 2020 | 3,903.00 |
| Jun 30, 2020 | -4,019.00 |
| Mar 31, 2020 | -1,039.00 |
| Dec 31, 2019 | 259.00 |
| Sep 30, 2019 | 1,713.00 |
| Jun 30, 2019 | 2,881.00 |
| Mar 31, 2019 | 14,114.00 |
| Dec 31, 2018 | -225,395.00 |
| Sep 30, 2018 | 244,572.00 |
| Jun 30, 2018 | -19,203.00 |
| Mar 31, 2018 | -117,977.00 |
| Dec 31, 2017 | 111,097.00 |
| Sep 30, 2017 | -469.00 |
| Jun 30, 2017 | 39,396.00 |
| Mar 31, 2017 | -17,392.00 |
| Dec 31, 2016 | -28,192.00 |
| Sep 30, 2016 | 62,258.00 |
| Jun 30, 2016 | 70,248.00 |
| Sep 30, 2015 | -40,771.00 |
| Jun 30, 2015 | 2,699.00 |
| Mar 31, 2014 | -10,763.00 |
| Dec 31, 2013 | 35,319.00 |
| Sep 30, 2013 | 1,501.00 |
| Jun 30, 2013 | -10,239.00 |
| Mar 31, 2013 | -42,062.00 |
| Dec 31, 2012 | 37,024.00 |
| Sep 30, 2012 | -28,563.00 |
| Jun 30, 2012 | 23,301.00 |
| Mar 31, 2012 | 12,608.00 |
| Dec 31, 2011 | 49,698.00 |
| Sep 30, 2011 | 939.00 |
| Jun 30, 2011 | -65,641.00 |
| Mar 31, 2011 | 61,157.00 |
| Dec 31, 2010 | -42,506.00 |